Cerus reported $64.72M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Atrion ATRI:US 14.82M 2.15M
Cerulean Pharma CERU:US $ 15.91M 9.9M
Cerus CERS:US $ 64.72M 1.1M
Cytori Therapeutics CYTX:US $ 9.49M 1.13M
GRIFOLS GRF:SM € 1921.48M 360.62M
Haemonetics HAE:US $ 288.47M 60.13M
Neogen NEOG:US $ 61.42M 10.66M
Nuvasive NUVA:US $ 195.36M 1.63M
Orasure Technologies OSUR:US $ 54.17M 7.6M
Quidel QDEL:US $ 297.09M 87.82M
Rockwell Medical RMTI:US $ 21.76M 12.28M
Sientra SIEN:US $ 71.68M 0.41M
Staar Surgical STAA:US $ 46.8M 5M
Terumo 4543:JP Y 185828M 2839M
Utah Medical Products UTMD:US $ 5.01M 448K